Viewing nowEsomel 20 mg Tablet (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 21.69mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

MFDS item code 201404651 · Approved 2014.10.10 · Insurance code 648602780
Treatment and prevention of acid-related disorders (such as reflux), ulcers and rebleeding, and gastrointestinal symptoms caused by anti-inflammatory analgesics
This medication is used for the long-term maintenance therapy of gastroesophageal reflux disease, erosive esophagitis treatment, and preventing recurrence in patients with esophagitis. It also helps in the treatment and prevention of recurrence of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection. It is effective in treating and preventing upper gastrointestinal symptoms or gastric ulcers associated with non-steroidal anti-inflammatory drugs and is also used for the treatment of Zollinger-Ellison syndrome. Furthermore, it is suitable for maintenance therapy to prevent rebleeding from gastric ulcers or duodenal ulcers. Overall, it is used to improve a variety of symptoms and diseases associated with gastrointestinal disorders.
This drug should be swallowed with a liquid such as water and should not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurrent symptoms may be controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurrent symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this drug 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug (nonselective or selective COX-2) use - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting more than 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug treatment - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. According to clinical data, most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following intravenous induction of prevention of rebleeding due to gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous induction of prevention of rebleeding due to gastric or duodenal ulcers. 4. Renal impairment: Dose adjustment is not necessary. Use with caution because there is limited experience in patients with severe renal failure. 5. Hepatic impairment: Dose adjustment is not necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this drug should not exceed 20 mg. 6. Older adults: Dose adjustment is not necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurrent symptoms may be controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurrent symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 3. Children under 12 years: There is no experience with administration of this drug to children under 12 years.
This medication should not be administered to certain patients. Patients with hypersensitivity to this drug or its components, or who have experienced such reactions in the past, should not use it. Additionally, when used in combination with amoxicillin or clarithromycin for Helicobacter pylori eradication, patients allergic to penicillin or macrolide antibiotics should also not be given this medication. It is also safer to avoid using this medication in patients on certain cardiac drugs, antiviral agents, and in nursing women. When taking this medication, attention is needed as various side effects may occur. Digestive symptoms like headache, abdominal pain, diarrhea, nausea, and vomiting are commonly reported, while rare cases may include hematological abnormalities, allergic reactions, mental symptoms, skin rashes, and liver function abnormalities. Especially, if muscle pain or weakness occurs, serious conditions like rhabdomyolysis should be suspected and immediate medical consultation is required. Regular check-ups are necessary when taken for extended periods. This medication decreases stomach acid secretion which may increase the risk of bacterial overgrowth in the stomach, thus if diarrhea persists, you should consult a doctor. Additionally, long-term use may increase the risk of fractures, so patients at risk of osteoporosis should be cautious. There may be a decrease in magnesium levels, requiring periodic checks of serum magnesium levels especially when taken long-term or in combination with certain medications. This medication may interact with other medications, so if there are concurrent medications, it is essential to inform healthcare providers. Caution is particularly needed when used with drugs affecting blood coagulation, antiviral agents, some antibiotics, and anticonvulsants. During pregnancy, safety data for this medication is limited, thus pregnant women should be cautious and consult a physician prior to use. Nursing mothers are advised not to take this medication. In case of overdose, there is no specific antidote, so appropriate treatment according to symptoms and general management is necessary. Finally, this medication should be kept out of reach of children, and transferring it to another container is not advisable for maintaining quality.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, agitation, mental confusion, depression, aggression, hallucination, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, Lyell syndrome, acute generalized pustular eruption, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reaction, back pain, chest pain, retrosternal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, dry mouth, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, convulsion, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, sensory decline, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorder, tremor, visual field loss, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngoeedema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, abnormal olfaction, loss of taste, taste aversion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, increased frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication may be weak against air or moisture, so it should be stored in a tightly sealed container. Additionally, it is important to store it at room temperature between 1°C and 30°C to maintain its effectiveness.
Pale pink round film-coated tablet
28 tablets (14 tablets/PTP x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 21.69mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.